Bitopertin Expanded Access Program

Disc Medicine has informed The American Porphyria Foundation that it is planning an Expanded Access Program (EAP) in the United States for Bitopertin for individuals living with EPP or XLP who are 12 years of age and older.

An Expanded Access Program may provide a pathway for certain patients to receive an investigational treatment outside of a clinical trial, provided they meet specific eligibility criteria.

The program is not yet open, and details are still being finalized. As more information becomes available including potential study sites and inclusion criteria we will share updates promptly.